Clinical Trials Browser

Interventional × vorolanib × Gastrointestinal × Clear all

NCT03286244 2019-02-21

Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer

Phase 1 Unknown

Gastrointestinal

Advanced Gastric Cancer